Harvard Bioscience (HBIO) Treasury Shares (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Treasury Shares of $10.7 million for Q1 2021, little changed year-over-year from $10.7 million in Q1 2020, and little changed quarter-over-quarter from $10.7 million in Q4 2020.
Harvard Bioscience (HBIO) Treasury Shares (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Treasury Shares for 12 consecutive years, with $10.7 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Treasury Shares changed 0.0% year-over-year to $10.7 million; the TTM figure through Mar 2021 stood at $10.7 million (changed 0.0% YoY), while the FY2020 annual figure was $10.7 million, changed 0.0% from the prior year.
- Treasury Shares was little changed at $10.7 million in Q1 2021 per HBIO's latest filing, from $10.7 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.1 million in Q1 2023 and bottomed at $50000.0 in Q4 2025.
- Historically, Treasury Shares has averaged $1.2 million across 5 years, with a median of $1.5 million in 2022.
- On a YoY basis, Treasury Shares climbed as much as 0.0% in 2017 and fell as far as 0.0% in 2017.
- Harvard Bioscience's Treasury Shares stood at $10.7 million in 2017, then changed by 0.0% to $10.7 million in 2018, then changed by 0.0% to $10.7 million in 2019, then changed by 0.0% to $10.7 million in 2020, then changed by 0.0% to $10.7 million in 2021.
- Business Quant data shows HBIO's Treasury Shares at $10.7 million in Q1 2021, $10.7 million in Q4 2020, and $10.7 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 98.21 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 46.80 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 355.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 23.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 166.50 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 389,495.00 |
| Jun 30, 2026 | 389,495.00 |
| Mar 31, 2026 | 50,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 432,521.00 |
| Jun 30, 2025 | 432,521.00 |
| Mar 31, 2025 | 496,697.00 |
| Mar 31, 2025 | 496,697.00 |
| Dec 31, 2024 | 375,895.00 |
| Dec 31, 2024 | 375,895.00 |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Mar 31, 2024 | 1.89 Mn |